Health Canada Special Access Program
This program allows health care practitioners to request drugs that are currently unavailable for sale in Canada. They are allowed to apply on behalf of patients with serious or life-threatening conditions when conventional therapies.
The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada. Drugs considered for release by the SAP include pharmaceutical, biologic, and radio-pharmaceutical products not approved for sale in Canada.
Contact: SAP Drugs. What is the Special Access Programme …